Discover trends, market shifts, and competitive outlooks for the venous thromboembolism industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The Venous Thromboembolism Market Growth Evolved From 2024 To 2025, And What’s Ahead?

There has been consistent growth in the venous thromboembolism market size over the past few years. The market which is projected to expand from $2.44 billion in 2024 to $2.55 billion in 2025, will experience a compound annual growth rate (CAGR) of 4.4%. This growth during the historic period is due primarily to factors such as an increasing aging population, advancements in anticoagulants, favorable reimbursement policies, and rising investments.

In the coming years, the venous thromboembolism market size is anticipated to witness consistent expansion, with forecasts predicting its value to reach $3.02 billion by 2029, growing at a compound annual growth rate (CAGR) of 4.4%. Factors influencing this growth during the forecast period include enhanced global healthcare access, evaluations of genetic risk, the advent of telemedicine and remote patient monitoring, as well as initiatives promoting patient education and support. Noteworthy trends projected for the forecast period encompass extended thromboprophylaxis, the development of novel oral anticoagulants, individualized treatment approaches, and advancements in diagnostic imaging technologies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13001&type=smp

What External and Internal Drivers Are Contributing to the Growth of the Venous Thromboembolism Market?

The growth of the venous thromboembolism market is anticipated to be driven by the expansion of the healthcare infrastructure. The healthcare industry, which encompasses the sectors of the economic system that offer products and services for the prevention, treatment, rehabilitation and palliative care of patients, is expanding. This growth paves the way for the development of institutional infrastructure, policies, practices and educational programs that are critical for the implementation of VTE prevention protocols. The American Health Care Association reported that in May 2023, the count of hospitals in the US increased to 6,129, up from 6,093 in 2022. According to the Office for National Statistics, healthcare expenditure in the UK in 2023 was around £292 billion, marking a nominal increase of 5.6%. Furthermore, long-term health and social care expenditure in 2022 grew in real terms by 2.8%. Therefore, the flourishing healthcare industry is pushing the growth of the venous thromboembolism market. The venous thromboembolism market is predicted to be buoyed by a surge in the number of orthopaedic procedures. These are surgical operations aimed at treating conditions impacting the spine and joints and rectifying skeletal deformities, such as total knee arthroplasty (TKA), total hip arthroplasty (THA), or hip fracture surgery (HFS). These operations carry a high VTE risk, leading to increased use of compression devices for DVT prophylaxis. These devices prevent the formation of blood clots in the deep veins of the legs, thus lowering the risk of VTE. As per data from the National Library of Medicine published in February 2023, it is projected that by 2040, there will be increases of 719,364 and 1,222,988 in THA and TKA procedures respectively. Furthermore, by 2060, it is anticipated that the number of TKAs will reach 2,917,959, while THAs will total 1,982,099. This rise in orthopaedic procedures is powering the growth of the venous thromboembolism market.

What Segment Types Define the Venous Thromboembolism Market Structure?

The venous thromboembolism market covered in this report is segmented –

1) By Type: Deep Vein Thrombosis, Pulmonary Embolism, Other Types

2) By Treatment: Anti-Clotting Medications,  Mechanical Devices, Thrombolytic Therapy, Other Treatment

3) By End Users: Hospitals, Homecare, Specialty Centers, Other End Users

Subsegments:

1) By Deep Vein Thrombosis (DVT): Proximal DVT, Distal DVT, Asymptomatic DVT

2) By Pulmonary Embolism (PE): Acute PE, Chronic PE, Submassive PE

3) By Other Types: Thrombophlebitis, Superficial Vein Thrombosis, Post-Thrombotic Syndrome

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13001&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Venous Thromboembolism Market?

North America was the largest region in the venous thromboembolism market in 2024. The regions covered in venous thromboembolism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Venous Thromboembolism Market?

Leading firms in the venous thromboembolism market are focusing on creating innovative anticoagulant medications to maintain their market standing. Improvements in anticoagulants can lead to the creation of more effective treatments for venous thromboembolism. For example, in September 2022, Anthos Therapeutics, an American clinical-stage biotherapeutic company, won regulatory approval from the U.S. Food and Drug Administration (FDA) for its new anticoagulant, abelacimab. The medication is a fully human monoclonal antibody designed to prevent strokes and systemic embolisms in patients with atrial fibrillation. The newly formulated, monthly dual-action antibody, abelacimab, is planned to induce hemostasis-sparing anticoagulation through the inhibition of Factor XI.

View the full report here:

https://www.thebusinessresearchcompany.com/report/venous-thromboembolism-global-market-report

What Is the Definition of the Venous Thromboembolism Market?

Venous thromboembolism (VTE) refers to a medical condition characterized by the formation of blood clots within the veins, which can lead to potentially serious or life-threatening complications. common symptoms of VTE include leg pain and swelling, rapid breathing, chest pain and more. The various treatment methods, such as anticoagulant medications, devices and thrombolytic therapy, are used for the treatment of VTE.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13001

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model